Details of the Drug Reposition

General Information of This Drug (ID: DMWE2N4)

Drug Name
Auranofin   DMWE2N4
Synonyms
Ridaura; Ridauran; Ridaura (TN); SK&F 39162; SK&F-39162; Gold, (1-thio-.beta.-D-glucopyranosato)(triethylphosphine)-, 2,3,4,6-tetraacetate; (1-Thio-.beta.-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate
Therapeutic Class
Antirheumatic Agents
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Blau syndrome DISRSNTO N.A. Discontinued in Phase 3 [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Rheumatoid arthritis DISTSB4J FA20 Discontinued in Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
2 Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx